Cefpodoxime labels and packages

Cefpodoxime Proxetil
VANTIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Rx only Licensed from Sankyo Company, Ltd., Japan

LAB-0035-5.0

April 2007

PRINCIPAL DISPLAY PANEL - 200 mg Tablet Bottle Label

6505-01-368-2870

Vantin® cefpodoxime proxetil tablets, USP

200 mg

100 Tablets

References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050674s015,050675s018lbl.pdf